Eisai
4523.T
#2354
Rank
S$10.65 B
Marketcap
S$37.74
Share price
-1.74%
Change (1 day)
-7.97%
Change (1 year)
Eisai is a Japanese pharmaceutical company that is engaged in the R&D of drugs for the treatment of dementia and Alzheimer.

EPS for Eisai (4523.T)

EPS in 2025 (TTM): S$1.14

According to Eisai's latest financial reports the company's current EPS (TTM) is S$1.10. In 2026 the company made an earnings per share (EPS) of S$1.10 a decrease over its 2025 EPS that were of S$1.39.

EPS history for Eisai from 2000 to 2025

Annual EPS

Year EPS Change
2026S$1.10-21.04%
2025S$1.3911.85%
2024S$1.24-32.63%
2023S$1.855.52%
2022S$1.75-74.01%
2021S$6.73-66.58%
2020S$20.1398.24%
2019S$10.1517.01%
2018S$8.6837.78%
2017S$6.30-27.62%
2016S$8.7035.33%
2015S$6.43-2.82%
2014S$6.62-27.66%
2013S$9.15-27.49%
2012S$12.62-12.67%
2011S$14.4588.08%
2010S$7.68-11.06%
2009S$8.64-390.15%
2008S-$2.98-127.78%
2007S$10.72347.11%
2006S$2.404.38%
2005S$2.307.4%
2004S$2.1443.03%
2003S$1.4925.09%
2002S$1.2052.67%
2001S$0.7869.76%
2000S$0.46